Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease

Diabetes and Metabolism

Volumn 30, Issue 1, 2004, Pages 67-74

  Frimat, L ^a,b   Loos Ayav, C ^a   Panescu, V ^a   Cordebar, N ^a   Briancon S ^a   Kessler, M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

End stage renal disease; Late referral; Medical care; Nephrological care; Type 2 diabetes

Indexed keywords

ALBUMIN; CALCIUM; PHOSPHORUS;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COMORBIDITY; DIALYSIS; EMERGENCY TREATMENT; FEMALE; FRANCE; GASTROINTESTINAL SYMPTOM; HEALTH STATUS; HEMATOCRIT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL SPECIALIST; MOBILIZATION; MORBIDITY; MORTALITY; NEPHROLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; PHOSPHATE BLOOD LEVEL; PHYSICAL DISABILITY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 1842559314     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70091-5     Document Type: Article

References (23)

1. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis, 1999, 34, 795-808.
2. Pommer W, Bressel F, Chen F, Molzahn M. There is room for improvement of preterminal care in diabetic patients with end-stage renal failure - The epidemiological evidence in Germany. Nephrol Dial Transplant, 1997, 12, 1318-20.
3. Chantrel F, Enache I, Bouiller M, et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant, 1999, 14, 129-36.
4. Jungers P. Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant, 2002, 17, 371-5.
5. Powe NR. Early referral in chronic kidney disease: an enormous opportunity for prevention. Am J Kidney Dis, 2003, 41, 505-7.
6. Levinsky N. Specialist evaluation in chronic kidney disease: too little, too late. Ann Intern Med, 2002, 137, 542-3.
7. Renders G, Valk G, Griffin S, Wagner E, Eijk J, Assendelft W. Interventions to improve the management of diabetes in primary care, outpatient, and communnity settings. Diabetes Care, 2001, 24, 1821-33.
8. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis, 2002, 39, (Suppl 1).
9. Parmar M. Chronic renal disease. BMJ, 2002, 325, 85-90.
10. Kessler M, Frimat L, Panescu V, Brianson S. Impact of nephrology referral on early and mid-term outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): Results of a 2-year Prospective, Community-Based Study. Am J Kidney Dis, 2003, 42, 474-85.
11. Halimi S, Zmirou D, Benhamou P, et al. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study). Diabetes Metab, 1999, 25, 507-12.
12. Leplège A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36 Manuel de l'utilisateur et guide d'interpré tation des scores. ESTEM ed. Paris: 2001.
13. Ware JE, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User's manual. Boston: The Health Institute; 1994.
14. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: the Netherlands cooperative study on the adequacy of dialysis. Am J Kidney Dis, 2000, 35, 69-79.
15. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31-41.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987, 40, 373-83.
17. Beddhu S, Bruns F, Saul M, Seddon P, Zeidel M. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med, 2000, 108, 609-13.
18. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM. Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int, 2000, 57, 2539-45.
19. Korevaar J, Jansen M, Dekker FW, et al. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet, 2001, 358, 1046-50.
20. Wilson R, Godwin M, Seguin R, et al. End-stage renal disease: factors affecting referral decisions by family physicians in Canada, the United States, and Britain. Am J Kidney Dis, 2001, 38, 42-8.
21. Fink JC, Burdick RA, Kurth SJ, et al. Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis, 1999, 34, 694-701.
22. Jungers P, Choukroun G, Robino C, et al. Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant, 2000, 15, 2000-6.
23. Gregg E, Beckles G, Williamson D, Leveille S, Langlois J, Engelgau M. Diabetes and physical disability among U.S. adults. Diabetes Care, 2000, 23, 1272-7.